Abstract 3902: A novel biologic ADI-TRAIL fusion protein benefits from structural and functional complementarity of its components arginine deiminase and TRAIL, induces cancer cell apoptosis in vitro, and inhibits tumor growth in vivo
Keyword(s):
2020 ◽
Vol 128
◽
pp. 110327
◽
Keyword(s):
2015 ◽
Vol 26
(6)
◽
pp. 1044-1057
◽
Keyword(s):
2015 ◽
Vol 11
(6)
◽
pp. 4671-4677
◽
Keyword(s):
2018 ◽
Vol 83
(6)
◽
pp. 1011-1026
◽
Keyword(s):
2020 ◽
Keyword(s):
2014 ◽
Vol 5
(4)
◽
pp. e1191-e1191
◽
Keyword(s):
Keyword(s):